{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T12:24:33Z","timestamp":1794313473746,"version":"4.9.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T00:00:00Z","timestamp":1600646400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T00:00:00Z","timestamp":1600646400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Metab"],"DOI":"10.1038\/s42255-020-00271-w","type":"journal-article","created":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T16:05:04Z","timestamp":1600704304000},"page":"1046-1061","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":79,"title":["Stable human regulatory T cells switch to glycolysis following TNF receptor 2 costimulation"],"prefix":"10.1038","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0148-7802","authenticated-orcid":false,"given":"Sander","family":"de Kivit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2470-6919","authenticated-orcid":false,"given":"Mark","family":"Mensink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna T.","family":"Hoekstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilana","family":"Berlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8920-7133","authenticated-orcid":false,"given":"Rico J. E.","family":"Derks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3850-9913","authenticated-orcid":false,"given":"Demi","family":"Both","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad A.","family":"Aslam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derk","family":"Amsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0746-8565","authenticated-orcid":false,"given":"Celia R.","family":"Berkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8043-5009","authenticated-orcid":false,"given":"Jannie","family":"Borst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,21]]},"reference":[{"key":"271_CR1","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.immuni.2019.01.020","volume":"50","author":"JB Wing","year":"2019","unstructured":"Wing, J. B., Tanaka, A. & Sakaguchi, S. Human FOXP3+ regulatory T cell heterogeneity and function in autoimmunity and cancer. Immunity 50, 302\u2013316 (2019).","journal-title":"Immunity"},{"key":"271_CR2","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/imr.12160","volume":"259","author":"EM Shevach","year":"2014","unstructured":"Shevach, E. M. & Thornton, A. M. tTregs, pTregs, and iTregs: similarities and differences. Immunol. Rev. 259, 88\u2013102 (2014).","journal-title":"Immunol. Rev."},{"key":"271_CR3","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/ni904","volume":"4","author":"JD Fontenot","year":"2003","unstructured":"Fontenot, J. D., Gavin, M. A. & Rudensky, A. Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4, 330\u2013336 (2003).","journal-title":"Nat. Immunol."},{"key":"271_CR4","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1126\/science.1079490","volume":"299","author":"S Hori","year":"2003","unstructured":"Hori, S., Nomura, T. & Sakaguchi, S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057\u20131061 (2003).","journal-title":"Science"},{"key":"271_CR5","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1371\/journal.pbio.0050038","volume":"5","author":"S Floess","year":"2007","unstructured":"Floess, S. et al. Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol. 5, e38 (2007).","journal-title":"PLoS Biol."},{"key":"271_CR6","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1182\/blood-2017-11-785865","volume":"131","author":"BR Blazar","year":"2018","unstructured":"Blazar, B. R., MacDonald, K. P. A. & Hill, G. R. Immune regulatory cell infusion for graft-versus-host disease prevention and therapy. Blood 131, 2651\u20132660 (2018).","journal-title":"Blood"},{"key":"271_CR7","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.immuni.2009.04.006","volume":"30","author":"JL Riley","year":"2009","unstructured":"Riley, J. L., June, C. H. & Blazar, B. R. Human T regulatory cell therapy: take a billion or so and call me in the morning. Immunity 30, 656\u2013665 (2009).","journal-title":"Immunity"},{"key":"271_CR8","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1182\/blood-2008-01-133967","volume":"112","author":"HJ Koenen","year":"2008","unstructured":"Koenen, H. J. et al. Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells. Blood 112, 2340\u20132352 (2008).","journal-title":"Blood"},{"key":"271_CR9","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1080\/14728222.2019.1586886","volume":"23","author":"J Medler","year":"2019","unstructured":"Medler, J. & Wajant, H. Tumor necrosis factor receptor-2 (TNFR2): an overview of an emerging drug target. Expert Opin. Ther. Targets 23, 295\u2013307 (2019).","journal-title":"Expert Opin. Ther. Targets"},{"key":"271_CR10","doi-asserted-by":"publisher","first-page":"444","DOI":"10.3389\/fimmu.2018.00444","volume":"9","author":"BL Salomon","year":"2018","unstructured":"Salomon, B. L. et al. Tumor necrosis factor alpha and regulatory T cells in oncoimmunology. Front. Immunol. 9, 444 (2018).","journal-title":"Front. Immunol."},{"key":"271_CR11","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/ni.3077","volume":"16","author":"A Huynh","year":"2015","unstructured":"Huynh, A. et al. Control of PI(3) kinase in Treg cells maintains homeostasis and lineage stability. Nat. Immunol. 16, 188\u2013196 (2015).","journal-title":"Nat. Immunol."},{"key":"271_CR12","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1182\/blood-2007-06-094482","volume":"111","author":"R Zeiser","year":"2008","unstructured":"Zeiser, R. et al. Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells. Blood 111, 453\u2013462 (2008).","journal-title":"Blood"},{"key":"271_CR13","doi-asserted-by":"publisher","first-page":"7797","DOI":"10.1073\/pnas.0800928105","volume":"105","author":"S Sauer","year":"2008","unstructured":"Sauer, S. et al. T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc. Natl Acad. Sci. USA 105, 7797\u20137802 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"271_CR14","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.immuni.2018.04.008","volume":"48","author":"E Cuadrado","year":"2018","unstructured":"Cuadrado, E. et al. Proteomic analyses of human regulatory T cells reveal adaptations in signaling pathways that protect cellular identity. Immunity 48, 1046\u20131059 (2018).","journal-title":"Immunity"},{"key":"271_CR15","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/j.celrep.2018.01.040","volume":"22","author":"AV Menk","year":"2018","unstructured":"Menk, A. V. et al. Early TCR signaling induces rapid aerobic glycolysis enabling distinct acute T cell effector functions. Cell Rep. 22, 1509\u20131521 (2018).","journal-title":"Cell Rep."},{"key":"271_CR16","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/S1074-7613(02)00323-0","volume":"16","author":"KA Frauwirth","year":"2002","unstructured":"Frauwirth, K. A. et al. The CD28 signaling pathway regulates glucose metabolism. Immunity 16, 769\u2013777 (2002).","journal-title":"Immunity"},{"key":"271_CR17","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1189\/jlb.2AB0514-273RR","volume":"97","author":"S Basu","year":"2015","unstructured":"Basu, S., Hubbard, B. & Shevach, E. M. Foxp3-mediated inhibition of Akt inhibits Glut1 (glucose transporter 1) expression in human T regulatory cells. J. Leukoc. Biol. 97, 279\u2013283 (2015).","journal-title":"J. Leukoc. Biol."},{"key":"271_CR18","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.4049\/jimmunol.1003613","volume":"186","author":"RD Michalek","year":"2011","unstructured":"Michalek, R. D. et al. Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. J. Immunol. 186, 3299\u20133303 (2011).","journal-title":"J. Immunol."},{"key":"271_CR19","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1084\/jem.20110278","volume":"208","author":"LZ Shi","year":"2011","unstructured":"Shi, L. Z. et al. HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J. Exp. Med. 208, 1367\u20131376 (2011).","journal-title":"J. Exp. Med."},{"key":"271_CR20","doi-asserted-by":"publisher","first-page":"12542","DOI":"10.1073\/pnas.1715363114","volume":"114","author":"N He","year":"2017","unstructured":"He, N. et al. Metabolic control of regulatory T cell (Treg) survival and function by Lkb1. Proc. Natl Acad. Sci. USA 114, 12542\u201312547 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"271_CR21","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1096\/fj.14-268409","volume":"29","author":"UH Beier","year":"2015","unstructured":"Beier, U. H. et al. Essential role of mitochondrial energy metabolism in Foxp3+ T-regulatory cell function and allograft survival. FASEB J. 29, 2315\u20132326 (2015).","journal-title":"FASEB J."},{"key":"271_CR22","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.cmet.2016.12.018","volume":"25","author":"A Angelin","year":"2017","unstructured":"Angelin, A. et al. Foxp3 reprograms T cell metabolism to function in low-glucose, high-lactate environments. Cell Metab. 25, 1282\u20131293 e1287 (2017).","journal-title":"Cell Metab."},{"key":"271_CR23","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1038\/ni.3577","volume":"17","author":"VA Gerriets","year":"2016","unstructured":"Gerriets, V. A. et al. Foxp3 and Toll-like receptor signaling balance Treg cell anabolic metabolism for suppression. Nat. Immunol. 17, 1459\u20131466 (2016).","journal-title":"Nat. Immunol."},{"key":"271_CR24","doi-asserted-by":"publisher","first-page":"e89160","DOI":"10.1172\/jci.insight.89160","volume":"2","author":"D Howie","year":"2017","unstructured":"Howie, D. et al. Foxp3 drives oxidative phosphorylation and protection from lipotoxicity. JCI Insight 2, e89160 (2017).","journal-title":"JCI Insight"},{"key":"271_CR25","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/ni.2005","volume":"12","author":"GM Delgoffe","year":"2011","unstructured":"Delgoffe, G. M. et al. The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2. Nat. Immunol. 12, 295\u2013303 (2011).","journal-title":"Nat. Immunol."},{"key":"271_CR26","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/ni.3365","volume":"17","author":"J Wei","year":"2016","unstructured":"Wei, J. et al. Autophagy enforces functional integrity of regulatory T cells by coupling environmental cues and metabolic homeostasis. Nat. Immunol. 17, 277\u2013285 (2016).","journal-title":"Nat. Immunol."},{"key":"271_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04392-5","volume":"9","author":"NM Chapman","year":"2018","unstructured":"Chapman, N. M. et al. mTOR coordinates transcriptional programs and mitochondrial metabolism of activated Treg subsets to protect tissue homeostasis. Nat. Commun. 9, 2095 (2018).","journal-title":"Nat. Commun."},{"key":"271_CR28","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.immuni.2016.02.022","volume":"44","author":"C Procaccini","year":"2016","unstructured":"Procaccini, C. et al. The proteomic landscape of human ex vivo regulatory and conventional T cells reveals specific metabolic requirements. Immunity 44, 712 (2016).","journal-title":"Immunity"},{"key":"271_CR29","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1038\/ni.3269","volume":"16","author":"V De Rosa","year":"2015","unstructured":"De Rosa, V. et al. Glycolysis controls the induction of human regulatory T cells by modulating the expression of FOXP3 exon 2 splicing variants. Nat. Immunol. 16, 1174\u20131184 (2015).","journal-title":"Nat. Immunol."},{"key":"271_CR30","doi-asserted-by":"publisher","first-page":"784","DOI":"10.3389\/fimmu.2018.00784","volume":"9","author":"S Yang","year":"2018","unstructured":"Yang, S., Wang, J., Brand, D. D. & Zheng, S. G. Role of TNF\u2013TNF receptor 2 Signal in regulatory T cells and Its therapeutic implications. Front. Immunol. 9, 784 (2018).","journal-title":"Front. Immunol."},{"key":"271_CR31","doi-asserted-by":"publisher","first-page":"13051","DOI":"10.1073\/pnas.1807499115","volume":"115","author":"KN Atretkhany","year":"2018","unstructured":"Atretkhany, K. N. et al. Intrinsic TNFR2 signaling in T regulatory cells provides protection in CNS autoimmunity. Proc. Natl Acad. Sci. USA 115, 13051\u201313056 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"271_CR32","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3389\/fimmu.2019.00038","volume":"10","author":"JM Marin Morales","year":"2019","unstructured":"Marin Morales, J. M. et al. Automated clinical grade expansion of regulatory T cells in a fully closed system. Front. Immunol. 10, 38 (2019).","journal-title":"Front. Immunol."},{"key":"271_CR33","doi-asserted-by":"crossref","unstructured":"Opstelten, R. et al. GPA33: A marker to identify stable human regulatory T cells. J. Immunol. 204, 3139\u20133148 (2020).","DOI":"10.4049\/jimmunol.1901250"},{"key":"271_CR34","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1038\/nature05563","volume":"445","author":"Y Zheng","year":"2007","unstructured":"Zheng, Y. et al. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 445, 936\u2013940 (2007).","journal-title":"Nature"},{"key":"271_CR35","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.4049\/jimmunol.181.4.2855","volume":"181","author":"TN Golovina","year":"2008","unstructured":"Golovina, T. N. et al. CD28 costimulation is essential for human T regulatory expansion and function. J. Immunol. 181, 2855\u20132868 (2008).","journal-title":"J. Immunol."},{"key":"271_CR36","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cels.2018.06.003","volume":"7","author":"LB Tanner","year":"2018","unstructured":"Tanner, L. B. et al. Four key steps control glycolytic flux in mammalian cells. Cell Syst. 7, 49\u201362 e48 (2018).","journal-title":"Cell Syst."},{"key":"271_CR37","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1172\/JCI76012","volume":"125","author":"VA Gerriets","year":"2015","unstructured":"Gerriets, V. A. et al. Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation. J. Clin. Invest. 125, 194\u2013207 (2015).","journal-title":"J. Clin. Invest."},{"key":"271_CR38","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.3389\/fimmu.2018.01849","volume":"9","author":"JH Shi","year":"2018","unstructured":"Shi, J. H. & Sun, S. C. Tumor necrosis factor receptor-associated factor regulation of nuclear factor \u03baB and mitogen-activated protein kinase pathways. Front. Immunol. 9, 1849 (2018).","journal-title":"Front. Immunol."},{"key":"271_CR39","doi-asserted-by":"publisher","first-page":"e0156311","DOI":"10.1371\/journal.pone.0156311","volume":"11","author":"X He","year":"2016","unstructured":"He, X. et al. A TNFR2-agonist facilitates high purity expansion of human low purity treg cells. PLoS ONE 11, e0156311 (2016).","journal-title":"PLoS ONE"},{"key":"271_CR40","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.cmet.2014.05.004","volume":"20","author":"AN Macintyre","year":"2014","unstructured":"Macintyre, A. N. et al. The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function. Cell Metab. 20, 61\u201372 (2014).","journal-title":"Cell Metab."},{"key":"271_CR41","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nature24057","volume":"551","author":"S Hui","year":"2017","unstructured":"Hui, S. et al. Glucose feeds the TCA cycle via circulating lactate. Nature 551, 115\u2013118 (2017).","journal-title":"Nature"},{"key":"271_CR42","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden, M. G., Cantley, L. C. & Thompson, C. B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029\u20131033 (2009).","journal-title":"Science"},{"key":"271_CR43","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.tibs.2016.02.003","volume":"41","author":"R Haas","year":"2016","unstructured":"Haas, R. et al. Intermediates of metabolism: from bystanders to signalling molecules. Trends Biochem. Sci. 41, 460\u2013471 (2016).","journal-title":"Trends Biochem. Sci."},{"key":"271_CR44","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/nri1248","volume":"3","author":"O Acuto","year":"2003","unstructured":"Acuto, O. & Michel, F. CD28-mediated co-stimulation: a quantitative support for TCR signalling. Nat. Rev. Immunol. 3, 939\u2013951 (2003).","journal-title":"Nat. Rev. Immunol."},{"key":"271_CR45","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.it.2014.12.001","volume":"36","author":"LS Walker","year":"2015","unstructured":"Walker, L. S. & Sansom, D. M. Confusing signals: recent progress in CTLA-4 biology. Trends Immunol. 36, 63\u201370 (2015).","journal-title":"Trends Immunol."},{"key":"271_CR46","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/0092-8674(95)90192-2","volume":"83","author":"M Grell","year":"1995","unstructured":"Grell, M. et al. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83, 793\u2013802 (1995).","journal-title":"Cell"},{"key":"271_CR47","doi-asserted-by":"publisher","first-page":"573","DOI":"10.3389\/fimmu.2018.00573","volume":"9","author":"PCM Urbano","year":"2018","unstructured":"Urbano, P. C. M., Koenen, H., Joosten, I. & He, X. An autocrine TNF\u03b1-tumor necrosis factor receptor 2 loop promotes epigenetic effects inducing human treg stability in vitro. Front. Immunol. 9, 573 (2018).","journal-title":"Front. Immunol."},{"key":"271_CR48","doi-asserted-by":"crossref","unstructured":"Kleijwegt, F. S. et al. Critical role for tnf in the induction of human antigen-specific regulatory T cells by tolerogenic dendritic cells. J. Immunol. 185, 1412 (2010).","DOI":"10.4049\/jimmunol.1000560"},{"key":"271_CR49","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1084\/jem.20151563","volume":"213","author":"M Chopra","year":"2016","unstructured":"Chopra, M. et al. Exogenous TNFR2 activation protects from acute GvHD via host T reg cell expansion. J. Exp. Med. 213, 1881\u20131900 (2016).","journal-title":"J. Exp. Med."},{"key":"271_CR50","doi-asserted-by":"publisher","first-page":"534","DOI":"10.2967\/jnumed.113.132761","volume":"55","author":"RA Herbertson","year":"2014","unstructured":"Herbertson, R. A. et al. Targeted chemoradiation in metastatic colorectal cancer: a phase I trial of 131I-huA33 with concurrent capecitabine. J. Nucl. Med. 55, 534\u2013539 (2014).","journal-title":"J. Nucl. Med."},{"key":"271_CR51","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang, D. et al. Metabolic regulation of gene expression by histone lactylation. Nature 574, 575\u2013580 (2019).","journal-title":"Nature"},{"key":"271_CR52","doi-asserted-by":"crossref","unstructured":"Williams, N. C. & O\u2019Neill, L. A. J. A role for the Krebs cycle intermediate citrate in metabolic reprogramming in innate immunity and inflammation. Front. Immunol. 9, 141 (2018).","DOI":"10.3389\/fimmu.2018.00141"},{"key":"271_CR53","doi-asserted-by":"publisher","first-page":"re4","DOI":"10.1126\/scisignal.2005970","volume":"8","author":"M Thurnher","year":"2015","unstructured":"Thurnher, M. & Gruenbacher, G. T lymphocyte regulation by mevalonate metabolism. Sci. Signal 8, re4 (2015).","journal-title":"Sci. Signal"},{"key":"271_CR54","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.1016\/j.celrep.2019.05.020","volume":"27","author":"M Timilshina","year":"2019","unstructured":"Timilshina, M. et al. Activation of mevalonate pathway via LKB1 is essential for stability of treg cells. Cell Rep. 27, 2948\u20132961 e2947 (2019).","journal-title":"Cell Rep."},{"key":"271_CR55","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/nature12297","volume":"499","author":"H Zeng","year":"2013","unstructured":"Zeng, H. et al. mTORC1 couples immune signals and metabolic programming to establish Treg-cell function. Nature 499, 485\u2013490 (2013).","journal-title":"Nature"},{"key":"271_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02672-0","volume":"9","author":"HD Brightbill","year":"2018","unstructured":"Brightbill, H. D. et al. NF-\u03baB inducing kinase is a therapeutic target for systemic lupus erythematosus. Nat. Commun. 9, 179 (2018).","journal-title":"Nat. Commun."},{"key":"271_CR57","doi-asserted-by":"publisher","first-page":"4288","DOI":"10.1093\/nar\/gks042","volume":"40","author":"DJ McCarthy","year":"2012","unstructured":"McCarthy, D. J., Chen, Y. & Smyth, G. K. Differential expression analysis of multifactor RNA-seq experiments with respect to biological variation. Nucleic Acids Res. 40, 4288\u20134297 (2012).","journal-title":"Nucleic Acids Res."},{"key":"271_CR58","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139\u2013140 (2010).","journal-title":"Bioinformatics"},{"key":"271_CR59","doi-asserted-by":"crossref","unstructured":"Chen, Y., Lun, A. & Smyth, G. From reads to genes to pathways: differential expression analysis of RNA-seq experiments using Rsubread and the edgeR quasi-likelihood pipeline. F1000Res 5, 1438 (2016).","DOI":"10.12688\/f1000research.8987.2"},{"key":"271_CR60","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"271_CR61","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The molecular signatures database hallmark gene set collection. Cell Syst. 1, 417\u2013425 (2015).","journal-title":"Cell Syst."},{"key":"271_CR62","doi-asserted-by":"publisher","first-page":"4021","DOI":"10.1021\/ac9004698","volume":"81","author":"KL Ross","year":"2009","unstructured":"Ross, K. L. & Dalluge, J. J. Liquid chromatography\/tandem mass spectrometry of glycolytic intermediates: deconvolution of coeluting structural isomers based on unique product ion ratios. Anal. Chem. 81, 4021\u20134026 (2009).","journal-title":"Anal. Chem."},{"key":"271_CR63","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1097\/01.ftd.0000179845.53213.39","volume":"27","author":"CA Smith","year":"2005","unstructured":"Smith, C. A. et al. METLIN: a metabolite mass spectral database. Ther. Drug Monit. 27, 747\u2013751 (2005).","journal-title":"Ther. Drug Monit."},{"key":"271_CR64","doi-asserted-by":"publisher","first-page":"3156","DOI":"10.1021\/acs.analchem.7b04424","volume":"90","author":"C Guijas","year":"2018","unstructured":"Guijas, C. et al. METLIN: a technology platform for identifying knowns and unknowns. Anal. Chem. 90, 3156\u20133164 (2018).","journal-title":"Anal. Chem."},{"key":"271_CR65","doi-asserted-by":"crossref","first-page":"3.16B.11","DOI":"10.1002\/0471142735.im0316bs113","volume":"113","author":"GJ van der Windt","year":"2016","unstructured":"van der Windt, G. J., Chang, C. H. & Pearce, E. L. Measuring bioenergetics in T cells using a seahorse extracellular flux analyzer. Curr. Protoc. Immunol. 113, 3.16B.11\u201313.16B.14 (2016).","journal-title":"Curr. Protoc. Immunol."},{"key":"271_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-13-153","volume":"13","author":"C Zhuo","year":"2014","unstructured":"Zhuo, C. et al. Higher FOXP3\u2013TSDR demethylation rates in adjacent normal tissues in patients with colon cancer were associated with worse survival. Mol. Cancer 13, 153 (2014).","journal-title":"Mol. Cancer"}],"container-title":["Nature Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42255-020-00271-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-020-00271-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-020-00271-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T03:13:47Z","timestamp":1670382827000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42255-020-00271-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,21]]},"references-count":66,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,10]]}},"alternative-id":["271"],"URL":"https:\/\/doi.org\/10.1038\/s42255-020-00271-w","relation":{},"ISSN":["2522-5812"],"issn-type":[{"value":"2522-5812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,21]]},"assertion":[{"value":"25 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors declare to have no financial or non-financial competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}